InvestAcc Group Announces Strong H1 2024 Results and Major Acquisitions in Pension Administration Sector
InvestAcc Group posts 16.3% H1 revenue growth to £10.5m, unveils transformative pension admin acquisitions and strategic Kartesia partnership for future M&A.
This article covers information on Investacc Group Limited.
LON:INACInvestAcc Flexes Muscles With Double Acquisition Play
Let’s cut straight to the chase – when a £10.5m revenue specialist pensions administrator starts throwing knockout punches in the M&A arena, savvy investors pay attention. InvestAcc’s H1 2024 results reveal a business executing a textbook consolidation strategy in Britain’s fragmented SIPP market. Here’s why this matters.
The Numbers That Matter
First, let’s digest the financial hors d’oeuvres:
- 16.3% revenue growth to £10.5m (H1 2024 vs FY23)
- Trading EBITDA up 15.7% to £4.2m
- 17.7% organic SIPP customer growth
- 98.4% service quality scores (because admin shouldn’t mean amateur hour)
But the real story lies in the strategic main course. InvestAcc isn’t just growing – it’s strategically feasting on market fragmentation.
The Consolidation Chessboard
InvestAcc’s playbook has two clear moves:
1. The Platform Play: Swallowing InvestAcc Holdings
October 2024’s acquisition wasn’t just a rebranding exercise. This brought:
- 12,467 active pension schemes
- £5.4bn assets under administration
- A 30-year pedigree in SIPP/SSAS administration
2. The Premium Move: Bagging AJ Bell’s Platinum Book
March 2025’s £25m Platinum SIPP/SSAS acquisition is the caviar to their fish fingers:
- 3,562 high-net-worth accounts
- Average SIPP size: £670k
- Adds £3.2bn AUA to the platform
Executive Chairman Mark Hodges puts it bluntly: “We’re building a market leader through consolidation.” Translation? They’re hoovering up quality books in a market where the top 5 players control less than half the assets.
The Financial Engine Room
Let’s talk fuel for this acquisition spree:
- 295% regulatory capital coverage (sleep-well-at-night ratio)
- £13.4m cash buffer post-H1
- £25m Kartesia debt facility (the acquisition war chest)
But the real genius? Their fee structure hasn’t changed in five years. With increases planned from H2 2025, expect margin expansion as pricing power kicks in.
The Hidden Growth Lever
Buried in the outlook – a £1m investment in treasury capabilities. Why care? Because better cash management =:
- Improved customer returns on cash balances
- New revenue stream from treasury operations
- Operational stickiness with advisers
This isn’t back-office tinkering – it’s a margin-enhancing masterstroke.
Risk Factors: The Elephant in the SIPP
No analysis is complete without red flags:
- Regulatory Roulette: Potential IHT rule changes loom, though management remains sanguine
- Integration Juggling: Migrating 9.5m data points to Delta Platinum Pro platform isn’t for the faint-hearted
- Valuation Vertigo: Paying 5-8x EBITDA for targets needs perfect execution
Yet with 96.5% customer retention and multiple industry awards, they’re clearly doing something right operationally.
The Verdict
InvestAcc isn’t just riding the consolidation wave – they’re orchestrating it. For investors, the calculus is simple:
- ✅ Proven acquisition integration capability
- ✅ Operational leverage from scale
- ✅ Structural growth in intergenerational wealth transfer
The pension admin space might not be sexy, but with £10.9tn of UK household wealth up for grabs, InvestAcc’s “buy, build and streamline” approach could deliver compound returns that would make even a SSAS investor blush.
Disclosure: This is analysis, not advice. Always do your own due diligence. But if you’re not watching this space, you’re missing one of Britain’s quiet financial services revolutions.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.